SCHEMBL328541

SCHEMBL328541

CC=Cc1ccc(O)c(O)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 4/20 0.73
CNR2 P34972 1/20 0.72
TYR P14679 1/20 0.62
NQO2 P16083 2/20 0.61
KDM4E B2RXH2 4/20 0.59
CYP3A4 P08684 3/20 0.59
ALDH1A1 P00352 3/20 0.59
HSD17B10 Q99714 3/20 0.59
ALOX5 P09917 3/20 0.59
ALOX12 P18054 2/20 0.59
CYP2C9 P11712 2/20 0.59
HIF1A Q16665 2/20 0.59
MEN1 O00255 2/20 0.59
LMNA P02545 2/20 0.59
TTR P02766 2/20 0.59
POLB P06746 2/20 0.59
MMP2 P08253 2/20 0.59
MAPT P10636 2/20 0.59
THRB P10828 2/20 0.59
MMP9 P14780 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9746195 1.00 LCK (0.73) LCKCNR2TYRNQO2KDM4E
SCHEMBL30433974 1.00 LCK (0.73) LCKCNR2TYRNQO2KDM4E
SCHEMBL152686 1.00 LCK (0.73) LCKCNR2TYRNQO2KDM4E
Methoxymethane SCHEMBL28116101 0.94 TYR (0.67) LCKCNR2TYRNQO2KDM4E
Formic Acid SCHEMBL29030376 0.92 CNR2 (0.62) LCKCNR2TYRNQO2KDM4E
Acetic Acid SCHEMBL29030398 0.90 IAPP (0.65) LCKCNR2TYRNQO2KDM4E
Propionic Acid SCHEMBL29030369 0.85 IAPP (0.63) LCKCNR2TYRKDM4ECYP3A4
SCHEMBL1824175 0.85 LCK (1.00) LCKNQO2KDM4ECYP3A4ALDH1A1
SCHEMBL31706727 0.85 LCK (1.00) LCKNQO2KDM4ECYP3A4ALDH1A1
SCHEMBL30631591 0.85 LCK (1.00) LCKNQO2KDM4ECYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116410367-A Catalyst system for ethylene polymerization and preparation method and application thereof 中国石油天然气股份有限公司 2023-07-11 CN claimed
EP-4318681-A1 HYDROPHILIC POLYMER AND MANUFACTURING METHOD THEREFOR, AND LITHIUM SECONDARY BATTERY COMPRISING HYDROPHILIC POLYMER Contemporary Amperex Technology Co., Limited (CN) 2024-02-07 EP disclosed
CN-117430487-A Method for directly preparing catechol and propylene from C-type lignin 中国科学院大连化学物理研究所 2024-01-23 CN disclosed
CN-113087843-B Polymer and photoresist composition containing same 北京鼎材科技有限公司 2023-10-13 CN disclosed
CN-116354813-A Phenolic acid compound and preparation method and application thereof 广东省科学院化工研究所 2023-06-30 CN disclosed
CN-116217891-A Intrinsic antibacterial epoxy resin precursor, composition, preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2023-06-06 CN disclosed
CN-108821930-B Ether bond cracking method of phenyl alkyl ether 荆楚理工学院 2021-11-05 CN disclosed
CN-113087843-A Polymer and photoresist composition containing same 北京鼎材科技有限公司 2021-07-09 CN disclosed
CN-106866377-B Ether bond breaking method of phenyl alkyl ether 荆楚理工学院 2020-06-09 CN disclosed
EP-1741439-B1 TRADITIONAL CHINESE MEDICINE PREPARATION FOR CARDIO-CEREBRAL BLOOD VESSEL DISEASES AND ITS PREPARING METHOD TASLY PHARMACEUTICAL GROUP CO (CN) 2017-05-31 EP disclosed
US-7396545-B2 Preparation for cardio-cerebral blood vessel diseases and its preparing method TIANJIN TASLY PHARMACEUTICAL CO., LTD. (CN) 2008-07-08 US disclosed
US-7396545-B2 Preparation for cardio-cerebral blood vessel diseases and its preparing method TIANJIN TASLY PHARMACEUTICAL CO., LTD. (CN) 2008-07-08 US disclosed
US-20070071834-A1 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method TASLY PHARMACEUTICAL GROUP CO., LTD (CN) 2007-03-29 US disclosed
US-20070071834-A1 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method TASLY PHARMACEUTICAL GROUP CO., LTD (CN) 2007-03-29 US disclosed
US-5087548-A POSITIVE TYPE RADIATION-SENSITIVE RESIN COMPOSITION JAPAN SYNTHETIC RUBBER CO., INC. (JP) 1992-02-11 US disclosed
EP-0104863-B1 LIGHT-SENSITIVE PLANOGRAPHIC PRINTING PLATE FUJI PHOTO FILM CO., LTD. (JP) 1989-05-03 EP disclosed
EP-0227487-A2 Positive type radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1987-07-01 EP disclosed
EP-0081777-B1 PROCESS TO PRODUCE VINYL CHLORIDE POLYMERS HOECHST AKTIENGESELLSCHAFT (DE) 1986-04-09 EP disclosed
US-4464516-A VESSEL COATED WITH SILANE RXN. PROD.; REDUCED REACTOR FOULING HOECHST AKTIENGESELLSCHAFT (DE) 1984-08-07 US disclosed
EP-0081777-A2 Process to produce vinyl chloride polymers HOECHST AKTIENGESELLSCHAFT (DE) 1983-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070071834-A1 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method CCNY, LIPG, MAG LCK 2626/4885CNR2 128/4885TYR 4235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.